Glaucoma awareness-raising strategies

Article

A multimedia campaign may be the best way to raise glaucoma awareness in the UK, according to study results published in the December issue of the British Journal of Ophthalmology.

A multimedia campaign may be the best way to raise glaucoma awareness in the UK, according to study results published in the December issue of the British Journal of Ophthalmology.

Mrs H. Baker of the Institute of Ophthalmology, London, UK and colleagues conducted a questionnaire assessing health knowledge and the effectiveness of an awareness-raising campaign conducted through television, local press and radio and places of worship over a six-month period. Attendance at ophthalmic practices before, during and after the campaign was also measured.

The level of questionnaire respondents aware of glaucoma before and after the awareness campaign increased from 22% to 53%, and the source of this information had moved away from word-of-mouth to radio. Attendance at ophthalmic practices did not change during or after the awareness campaign.

The team concluded that radio advertising was the best way of increasing awareness of glaucoma, although it did not influence health-seeking behaviour.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.